Am J Transplant, Volume 19, Suppl 3 Archives - Page 206 of 214 - ATC Abstracts

2019 American Transplant Congress
Single Center Deceased Donor Renal Transplant (DDRTx) Outcomes in Sensitized Patients after Implementation of the Kidney Allocation System (KAS)
S. S. Patel, K. L. King, J. Kamal, E. Vasilescu, A. Husain, S. Mohan, L. E. Ratner, R. Crew
Columbia University Irving Medical Center, New York, NY
*Purpose: Introduction of KAS in 2014 prioritized access to DDRTx for highly-sensitized candidates although it was unclear whether the outcomes would be acceptable in this…
2019 American Transplant Congress
Risk of Delayed Graft Function after Deceased Donor Kidney Transplantation in the Current Era
I. Helanterä¹, H. N. Ibrahim², M. Lempinen¹, P. Finne³
¹Transplantation and Liver Surgery, Helsinki University Hospital, Helsinki, Finland, ²Department of Medicine, Houston Methodist Hospital, Houston, TX, ³Nephrology, Helsinki University Hospital, Helsinki, Finland
*Purpose: Delayed graft function (DGF) is associated with morbidity and cost after deceased donor kidney transplantation. Some data suggest that previously sensitized patients and kidneys…
2019 American Transplant Congress
Early Conversion to Belatacept in High Risk Renal Transplant Recipients
A. Santeusanio, A. Bhansali, R. Shapiro, V. Delaney, S. Florman, G. De Boccardo
Mount Sinai Hospital, New York, NY
*Purpose: This study describes our experience with early conversion to belatacept therapy in a diverse patient population including patients with donor specific antibodies (DSA). The…
2019 American Transplant Congress
Conversion to Belatacept in Kidney Transplant Recipients with Systemic Lupus Erythematosus
I. Carrión Barberà, M. C. Fajardo, D. Tsapepas, J. Gartshteyn, A. Askanase, H. E. Fernandez
Columbia University MC, New York, NY
*Purpose: Lupus nephritis (LN) results in the need for renal replacement therapy (RRT) in 10-30% of LN pts and 30% receive a kidney transplant (KT).…
2019 American Transplant Congress
Sirolimus (SRL) versus Everolimus (EVR) versus Mycophenolate (MPA) in Kidney Transplant Recipients Receiving Anti-Thymocyte Globulin Induction (r-ATG), Tacrolimus (TAC), and Prednisone
C. Rosso Felipe, L. Viana, M. Pontello Cristelli, J. Toniato, K. Ficher, S. Poletto, H. Proença, R. de Marco, M. Gerbase-Lima, A. Brigido, J. Medina Pestana, H. Tedesco-Silva
Hospital do Rim, Nephrology Division, EPM - UNIFESP, São Paulo, Brazil
*Purpose: TAC and MPA combination is considered the standard of care immunosuppressive regimen in the majority of transplant centers worldwide. Yet, given the lack of…
2019 American Transplant Congress
Risk Stratification of Patients Undergoing Simultaneous Liver Transplantation and Cardiac Surgery
T. Diago Uso, G. D'Amico, S. Armanyous, L. Lomaglio, B. Eghtesad, M. Fujiki, F. Aucejo, K. Sasaki, N. K. Menon, M. Fares, M. Tong, K. Hashimoto, C. Miller, C. Quintini
Cleveland Clinic, Cleveland, OH
*Purpose: Evaluate risk factors and outcomes of combined liver transplantation (OLT) and cardiac surgery, including coronary artery grafting and valve replacement.*Methods: Between 1/2005 and 8/2018,…
2019 American Transplant Congress
Utility Of SIPAT Scoring System In Predicting Risk Of Recidivism In Patients With Alcoholic Liver Disease.
A. Ur Rahman¹, H. Singh¹, M. Abusaif¹, J. Shaw², O. Knighton², L. Clark², T. Santos², S. Ebaid², D. Reino², J. Vanatta², A. Tzakis², K. Alkhalloufi², X. Zervos²
¹Gastroenterology, Cleveland Clinic Florida, Weston, FL, ²Transplant Institute, Cleveland Clinic Florida, Weston, FL
*Purpose: The Stanford Integrated Psychosocial Assessment for Transplant (SIPAT) score is a comprehensive tool that was developed to standardize pretransplant psychosocial evaluations and has been…
2019 American Transplant Congress
Liver Transplant Outcomes in Patients with Atrial Fibrillation
D. Devuni¹, P. Mahboub², P. Martins², C. Barry¹, I. Zacharias¹, B. Movahedi², G. Barnard¹, A. Bozorgzadeh²
¹Division of Gastroenterology, University of Massachusetts Medical School, Worcester, MA, ²Surgery, Division of Transplantation, University of Massachusetts Medical School, Worcester, MA
*Purpose: There is an increase in percentage of patients over the age of 65 yrs. who are being listed for liver transplantation (LT). Patients with…
2019 American Transplant Congress
Evaluation of an Invasive Fungal Infection Prophylaxis Strategy after Liver Transplantation at a Large Academic Medical Center
M. Jorgenson¹, J. Descourouez¹, D. Felix¹, N. Marka², G. Leverson², J. Smith², L. Fernandez², D. Foley²
¹UW Health, Madison, WI, ²University of Wisconsin School of Medicine and Public Health, Madison, WI
*Purpose: Invasive fungal infection (IFI) after liver transplant (LTx) is associated with increased morbidity and mortality. Studies show that IFI prophylaxis improves outcomes but the…
2019 American Transplant Congress
Patterns Of Anti-retroviral Use Among U.s. Liver Transplant Candidates With Hiv
A. A. Shaffer¹, A. G. Thomas², D. L. Segev³
¹Johns Hopkins University, Baltimore, MD, ²Epidemiology, University of North Carolina, Chapel Hill, NC, ³Surgery & Epidemiology, Johns Hopkins University, Baltimore, MD
*Purpose: There is a high burden of liver disease among HIV-infected (HIV+) individuals, and the class of antiretroviral therapy (ART) used for their treatment may…